Benefits of participation in diabetes group visits after trial completion

JAMA Internal Medicine

Volumn 173, Issue 7, 2013, Pages 590-592

  Jackson, George L ^a   Edelman, David ^a   Olsen, Maren K ^a   Smith, Valerie A ^a   Maciejewski, Matthew L ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

DIABETES MELLITUS; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HUMAN; MEDICAL RECORD; NOTE; OUTCOME ASSESSMENT; OUTPATIENT CARE; PATIENT CARE; PHARMACIST; PRIORITY JOURNAL; PROBABILITY; SYSTOLIC BLOOD PRESSURE;

DIABETES MELLITUS, TYPE 2; GROUP PROCESSES; HYPERTENSION; PATIENT PARTICIPATION; UNITED STATES;

EID: 84876049638     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.2803     Document Type: Note

References (9)

1. Edelman D, McDuffie JR, Oddone E, Gierisch JM, Nagi A, Williams JW. Shared Medical Appointments for Chronic Medical Conditions: A Systematic Review. Washington, DC: Evidence Synthesis Program, Health Services Research& Development Service, Veterans Health Administration, US Dept of Veterans Affairs; 2012. ESP Project 09-10.
2. Edelman D, Fredrickson SK, Melnyk SD, et al. Medical clinics versus usual care for patients with both diabetes and hypertension: a randomized trial. Ann Intern Med. 2010;152(11):689-696.
3. Fredrickson S, Coffman CJ, Weinberger M, et al. Group medical visits improve lipid profiles in patients with diabetes and hypertension. J Gen Intern Med. 2009;24(S1):S80-S81.
4. Maciejewski ML, Maynard C. Diabetes-related utilization and costs for inpatient and outpatient services in the Veterans Administration. Diabetes Care. 2004;27(suppl 2):B69-B73.
5. Phibbs CS, Barnett PG, Fan A, Harden C, King SS, Scott JY. Research Guide to Decisions Support System National Cost Extracts. Menlo Park, CA: Health Economics Resource Center of Health Services Research & Development Service, US Dept of Veterans Affairs; September 2010.
6. Witte JS, Greenland S. A nested approach to evaluating dose-response and trend. Ann Epidemiol. 1997;7(3):188-193.
7. Healthcare Cost and Utilization Project (HCUP). Clinical Classifications Software (CCS) for ICD-9-CM. Rockville, MD: Agency for Healthcare Research and Quality. August 2012. http://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp. Accessed August 2, 2012.
8. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577-1589.
9. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358(6):580-591.